Advertisement vbandhakavi, Author at Pharmaceutical Business review - Page 11 of 194
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

All articles by vbandhakavi 

Noramco buys Drug Product Business Unit from Cambrex

This acquisition will expand the range of services available to Noramco and its subsidiary Purisys’ active pharmaceutical ingredients (API) customers. The services include drug product formulation development, clinical

Basilea, iNtRON sign deal for antibacterial agent

Next year, Basilea will explore multiple hypotheses through preclinical studies to identify the optimal future clinical development programme for tonabacase. Under an exclusive option, Basilea will license tonabacase